|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Saraiya M, Patel P, Cherala SS,
Barnholtz-Sloan J, Kim J, Wiggins CL and Wingo PA: Recent trends in
cutaneous melanoma incidence and death rates in the United States,
1992–2006. J Am Acad Dermatol. 65 Suppl 1:S17–S25.e1-3. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Thun M, Yu XQ, Hartman AM,
Cokkinides V, Center MM, Ross H and Ward EM: Changes in smoking
prevalence among U.S. adults by state and region: Estimates from
the Tobacco Use Supplement to the Current Population Survey,
1992–2007. BMC Public Health. 11:5122011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yano M, Sasaki H, Moriyama S, Hikosaka Y,
Yokota K, Kobayashi S, Hara M and Fujii Y: Post-operative acute
exacerbation of pulmonary fibrosis in lung cancer patients
undergoing lung resection. Interact Cardiovasc Thorac Surg.
14:146–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yano M, Sasaki H, Moriyama S, Kawano O,
Hikosaka Y and Fujii Y: Prognostic factors of pathologic stage IB
non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 17:58–62.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yano T, Haro A, Shikada Y, Maruyama R and
Maehara Y: Non-small cell lung cancer in never smokers as a
representative ‘non-smoking-associated lung cancer’: Epidemiology
and clinical features. Int J Clin Oncol. 16:287–293. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brownson RC, Alavanja MC, Caporaso N,
Simoes EJ and Chang JC: Epidemiology and prevention of lung cancer
in nonsmokers. Epidemiol Rev. 20:218–236. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kołodziej Ł, Boczar T, Bohatyrewicz A and
Zietek P: Outcome of operative treatment for supination-external
rotation Lauge-Hansen stage IV ankle fractures. Chir Narzadow Ruchu
Ortop Pol. 75:231–235. 2010.(In Polish). PubMed/NCBI
|
|
10
|
Kadara H, Kabbout M and Wistuba II:
Pulmonary adenocarcinoma: A renewed entity in 2011. Respirology.
17:50–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gubbay J, Collignon J, Koopman P, Capel B,
Economou A, Münsterberg A, Vivian N, Goodfellow P and Lovell-Badge
R: A gene mapping to the sex-determining region of the mouse Y
chromosome is a member of a novel family of embryonically expressed
genes. Nature. 346:245–250. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakamoto Y, Hara K, Kanai-Azuma M, Matsui
T, Miura Y, Tsunekawa N, Kurohmaru M, Saijoh Y, Koopman P and Kanai
Y: Redundant roles of Sox17 and Sox18 in early cardiovascular
development of mouse embryos. Biochem Biophys Res Commun.
360:539–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wegner M: From head to toes: The multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chung MI, Ma AC, Fung TK and Leung AY:
Characterization of Sry-related HMG box group F genes in zebrafish
hematopoiesis. Exp Hematol. 39:986–998.e5. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
François M: Sox18 orchestrates the
commitment of the lymphatic vessels. Med Sci (Paris). 25:127–129.
2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
17
|
François M, Caprini A, Hosking B, Orsenigo
F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M,
et al: Sox18 induces development of the lymphatic vasculature in
mice. Nature. 456:643–647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Francois M, Koopman P and Beltrame M: SoxF
genes: Key players in the development of the cardio-vascular
system. Int J Biochem Cell Biol. 42:445–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Milivojevic M, Petrovic I,
Kovacevic-Grujicic N, Popovic J, Mojsin M and Stevanovic M:
Construction and functional analysis of novel dominant-negative
mutant of human SOX18 protein. Biochemistry (Mosc). 78:1287–1292.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu Y, Li Y, Jun Wei JW and Liu X: The
role of Sox genes in lung morphogenesis and cancer. Int J Mol Sci.
13:15767–15783. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saitoh T and Katoh M: Expression of human
SOX18 in normal tissues and tumors. Int J Mol Med. 10:339–344.
2002.PubMed/NCBI
|
|
22
|
Eom BW, Jo MJ, Kook MC, Ryu KW, Choi IJ,
Nam BH, Kim YW and Lee JH: The lymphangiogenic factor SOX 18: a key
indicator to stage gastric tumor progression. Int J Cancer.
131:41–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Young N, Hahn CN, Poh A, Dong C, Wilhelm
D, Olsson J, Muscat GE, Parsons P, Gamble JR and Koopman P: Effect
of disrupted SOX18 transcription factor function on tumor growth,
vascularization, and endothelial development. J Natl Cancer Inst.
98:1060–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jethon A, Pula B, Olbromski M, Werynska B,
Muszczynska-Bernhard B, Witkiewicz W, Dziegiel P and
Podhorska-Okolow M: Prognostic significance of SOX18 expression in
non-small cell lung cancer. Int J Oncol. 46:123–132. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pula B, Kobierzycki C, Solinski D,
Olbromski M, Nowak-Markwitz E, Spaczynski M, Kedzia W, Zabel M and
Dziegiel P: SOX18 expression predicts response to platinum-based
chemotherapy in ovarian cancer. Anticancer Res. 34:4029–4037.
2014.PubMed/NCBI
|
|
27
|
Pula B, Olbromski M, Wojnar A,
Gomulkiewicz A, Witkiewicz W, Ugorski M, Dziegiel P and
Podhorska-Okolow M: Impact of SOX18 expression in cancer cells and
vessels on the outcome of invasive ductal breast carcinoma. Cell
Oncol (Dordr). 36:469–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kasinski AL and Slack FJ: miRNA-34
prevents cancer initiation and progression in a therapeutically
resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
Cancer Res. 72:5576–5587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yin H, Sheng Z, Zhang X, Du Y, Qin C, Liu
H, Dun Y, Wang Q, Jin C, Zhao Y, et al: Overexpression of SOX18
promotes prostate cancer progression via the regulation of TCF1,
c-Myc, cyclin D1 and MMP-7. Oncol Rep. 37:1045–1051. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Devaraj S and Natarajan J: miRNA-mRNA
network detects hub mRNAs and cancer specific miRNAs in lung
cancer. In Silico Biol. 11:281–295. 2011-2012.
|
|
32
|
Ferracin M, Bassi C, Pedriali M, Pagotto
S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L,
et al: miR-125b targets erythropoietin and its receptor and their
expression correlates with metastatic potential and ERBB2/HER2
expression. Mol Cancer. 12:1302013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goswami S, Tarapore RS, Strong AM
Poenitzsch, TeSlaa JJ, Grinblat Y, Setaluri V and Spiegelman VS:
MicroRNA-340-mediated degradation of microphthalmia-associated
transcription factor (MITF) mRNA is inhibited by coding region
determinant-binding protein (CRD-BP). J Biol Chem. 290:384–395.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang C, Hu X, Alattar M and Zhao H: miRNA
expression profiles associated with diagnosis and prognosis in lung
cancer. Expert Rev Anticancer Ther. 14:453–461. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mairinger FD, Ting S, Werner R, Walter RF,
Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T,
Sheu-Grabellus SY, et al: Different micro-RNA expression profiles
distinguish subtypes of neuroendocrine tumors of the lung: results
of a profiling study. Mod Pathol. 27:1632–1640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoo JK, Jung HY, Lee JM, Yi H, Oh SH, Ko
HY, Yoo H, Kim HR, Song H, Kim S, et al: The novel miR-9500
regulates the proliferation and migration of human lung cancer
cells by targeting Akt1. Cell Death Differ. 21:1150–1159. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lovell-Badge R: The early history of the
Sox genes. Int J Biochem Cell Biol. 42:378–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Downes M, François M, Ferguson C, Parton
RG and Koopman P: Vascular defects in a mouse model of
hypotrichosis-lymphedema-telangiectasia syndrome indicate a role
for SOX18 in blood vessel maturation. Hum Mol Genet. 18:2839–2850.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo M, Guo XT, Yang W, Liu LQ, Li LW and
Xin XY: Inhibition of tumor angiogenesis by cell-permeable dominant
negative SOX18 mutants. Med Hypotheses. 70:880–882. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: Biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Olbromski M, Grzegrzolka J,
Jankowska-Konsur A, Witkiewicz W, Podhorska-Okolow M and Dziegiel
P: MicroRNAs modulate the expression of the SOX18 transcript in
lung squamous cell carcinoma. Oncol Rep. 36:2884–2892. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dammann R, Strunnikova M, Schagdarsurengin
U, Rastetter M, Papritz M, Hattenhorst UE, Hofmann HS, Silber RE,
Burdach S and Hansen G: CpG island methylation and expression of
tumour-associated genes in lung carcinoma. Eur J Cancer.
41:1223–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Azhikina T, Kozlova A, Skvortsov T and
Sverdlov E: Heterogeneity and degree of TIMP4, GATA4, SOX18, and
EGFL7 gene promoter methylation in non-small cell lung cancer and
surrounding tissues. Cancer Genet. 204:492–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Alonso MM, Diez-Valle R, Manterola L,
Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, de Munain
A Lopez, Sampron N, et al: Genetic and epigenetic modifications of
Sox2 contribute to the invasive phenotype of malignant gliomas.
PLoS One. 6:e267402011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Otsubo T, Akiyama Y, Yanagihara K and
Yuasa Y: SOX2 is frequently downregulated in gastric cancers and
inhibits cell growth through cell-cycle arrest and apoptosis. Br J
Cancer. 98:824–831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lang Y, Xu S, Ma J, Wu J, Jin S, Cao S and
Yu Y: MicroRNA-429 induces tumorigenesis of human non-small cell
lung cancer cells and targets multiple tumor suppressor genes.
Biochem Biophys Res Commun. 450:154–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F,
Bao G, Kong H, Ge C, Zhang F, et al: miRNA-200c inhibits invasion
and metastasis of human non-small cell lung cancer by directly
targeting ubiquitin specific peptidase 25. Mol Cancer. 13:1662014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Salim H, Akbar NS, Zong D, Vaculova AH,
Lewensohn R, Moshfegh A, Viktorsson K and Zhivotovsky B: miRNA-214
modulates radiotherapy response of non-small cell lung cancer cells
through regulation of p38MAPK, apoptosis and senescence. Br J
Cancer. 107:1361–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun Q, Hang M, Guo X, Shao W and Zeng G:
Expression and significance of miRNA-21 and BTG2 in lung cancer.
Tumour Biol. 34:4017–26. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xie C, Han Y, Liu Y, Han L and Liu J:
miRNA-124 down-regulates SOX8 expression and suppresses cell
proliferation in non-small cell lung cancer. Int J Clin Exp Pathol.
7:7518–7526. 2014.PubMed/NCBI
|
|
52
|
Zhang C, Ge S, Hu C, Yang N and Zhang J:
MiRNA-218, a new regulator of HMGB1, suppresses cell migration and
invasion in non-small cell lung cancer. Acta Biochim Biophys Sin
(Shanghai). 45:1055–1061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cermenati S, Moleri S, Cimbro S, Corti P,
Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F and Beltrame
M: Sox18 and Sox7 play redundant roles in vascular development.
Blood. 111:2657–2666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Duong T, Koltowska K, Pichol-Thievend C,
Le Guen L, Fontaine F, Smith KA, Truong V, Skoczylas R, Stacker SA,
Achen MG, et al: VEGFD regulates blood vascular development by
modulating SOX18 activity. Blood. 123:1102–1112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Duong T, Proulx ST, Luciani P, Leroux JC,
Detmar M, Koopman P and Francois M: Genetic ablation of SOX18
function suppresses tumor lymphangiogenesis and metastasis of
melanoma in mice. Cancer Res. 72:3105–3114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fontaine F, Overman J, Moustaqil M,
Mamidyala S, Salim A, Narasimhan K, Prokoph N, Robertson AA, Lua L,
Alexandrov K, et al: Small-molecule inhibitors of the SOX18
transcription factor. Cell Chem Biol. 24:346–359. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lv J and Xu L, Xu Y, Qiu M, Yang X, Wang
J, Yin R and Xu L: Expression of MiRNA-221 in non-small cell lung
cancer tissues and correlation with prognosis. Zhongguo Fei Ai Za
Zhi. 17:221–225. 2014.(Abstract in English). PubMed/NCBI
|
|
58
|
Brock M, Samillan VJ, Trenkmann M,
Schwarzwald C, Ulrich S, Gay RE, Gassmann M, Ostergaard L, Gay S,
Speich R, et al: AntagomiR directed against miR-20a restores
functional BMPR2 signalling and prevents vascular remodelling in
hypoxia-induced pulmonary hypertension. Eur Heart J. 35:3203–3211.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Selvamani A, Sathyan P, Miranda RC and
Sohrabji F: An antagomir to microRNA Let7f promotes neuroprotection
in an ischemic stroke model. PLoS One. 7:e326622012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Song MS and Rossi JJ: The anti-miR21
antagomir, a therapeutic tool for colorectal cancer, has a
potential synergistic effect by perturbing an
angiogenesis-associated miR30. Front Genet. 4:3012014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Faghihi MA, Zhang M, Huang J, Modarresi F,
Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G III and
Wahlestedt C: Evidence for natural antisense transcript-mediated
inhibition of microRNA function. Genome Biol. 11:R562010.
View Article : Google Scholar : PubMed/NCBI
|
